Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomised Open Label Trial of Oxaliplatin/Fluoropyrimidine Versus Oxaliplatin/Fluoropyrimidine Plus Cetuximab Pre and Post Operatively in Patients With Resectable Colorectal Liver Metastasis Requiring Chemotherapy

NCT00482222 is registered in ClinicalTrials.gov with University of Southampton as lead sponsor.

NCT NCT00482222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00482222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomised Open Label Trial of Oxaliplatin/Fluoropyrimidine Versus Oxaliplatin/Fluoropyrimidine Plus Cetuximab Pre and Post Operatively in Patients With Resectable Colorectal Liver Metastasis Requiring Chemotherapy
Lead sponsor
University of Southampton
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2007
Completion date
Not reported
Enrollment
340 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, metastatic cancer